论文部分内容阅读
眼科用药目前相对地来说少于其它病种的药物,其中一个原因是,由于一大批药物虽然对多种眼疾有相当好的疗效,但因性能不稳定,不能确保使用期和贮存期,因而不能作为商品进入医药市场,多数限于医院药房临时配制使用。如何使不稳定性的药物能投入工业化生产,是本文探索和介绍的重点。传统的眼科药物多为眼药水及眼药膏,其中水剂是重点,如氯霉素眼药水、新斯的明眼药水、疱疹净眼药水等,以及少量的混悬剂,如氢化可的松眼药水、酞丁安眼药水等。正因为如此,中国药典(77年版)附录8页对滴眼
One of the reasons that ophthalmological use is currently relatively less than that of other illnesses is due to the fact that a large number of drugs, although having a very good curative effect on a wide range of eye diseases, are not stable in performance and do not ensure pot life and shelf life Can not enter the pharmaceutical market as a commodity, most limited to the temporary preparation of the hospital pharmacy use. How to make the unstable drug can be put into industrial production is the focus of this article to explore and introduce. Traditional ophthalmic drugs and eye drops are mostly ophthalmic ointment, which is the focus of water, such as chloramphenicol eye drops, Neos eye drops, herpes net eye drops, and small amounts of suspensions such as hydrocortisone Eye drops, phthalocyanine eye drops and so on. Because of this, Chinese Pharmacopoeia (77 edition) Appendix 8 page on the eye drops